e8vk
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 22, 2010
BioMed Realty Trust, Inc.
(Exact name of registrant as specified in its charter)
         
Maryland   1-32261   20-1142292
         
(State or Other Jurisdiction   (Commission File No.)   (I.R.S. Employer
of       Identification No.)
Incorporation)        
17190 Bernardo Center Drive
San Diego, California 92128

(Address of principal executive offices, including zip code)
Registrant’s telephone number, including area code: (858) 485-9840
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


 

Item 8.01 Other Events.
     On April 22, 2010, BioMed Realty Trust, Inc. announced that its operating partnership subsidiary, BioMed Realty, L.P., priced the private placement of $250,000,000 aggregate principal amount of 6.125% Senior Notes due 2020. The press release announcing the pricing of this private placement is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) The following exhibits are filed herewith:
     
Exhibit    
Number   Description of Exhibit
99.1
  Press release issued by BioMed Realty Trust, Inc. on April 22, 2010.

 


 

SIGNATURES
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
Date: April 28, 2010  BIOMED REALTY TRUST, INC.
 
 
  By:   /s/ KENT GRIFFIN    
    Name:   Kent Griffin   
    Title:   President, Chief Operating Officer and Chief Financial Officer   

 


 

         
Exhibit Index
     
Exhibit    
Number   Description of Exhibit
99.1
  Press release issued by BioMed Realty Trust, Inc. on April 22, 2010.